
United Therapeutics Corporation
United Therapeutics Corporation (UTHR) Cash on Hand — Cash & Short-Term Investments
Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.
UTHR · cash on hand · updated Dec 31, 2025
Core cash position
as of Dec 31, 2025Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.
Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD
Net cash vs debt
Cash vs Debt · Balance Sheet HealthUnited Therapeutics Corporation has a net cash position of $1.56B, holding more cash than debt.
Cash on hand history
Annual cash on hand by year
UTHR cash & short-term investments historyHealthcare Sector Cash Reserves Comparison
About cash on hand & methodology
United Therapeutics Corporation (UTHR) cash on hand as of December 31, 2025 is $1.56B, comprising $1.56B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as United Therapeutics Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as United Therapeutics Corporation cash reserves or cash position.
United Therapeutics Corporation annual cash on hand history shows decreased -52.3% in 2025: decreased -52.3% in 2025. United Therapeutics Corporation cash reserves in 2025 reflect the company's capital allocation strategy.
United Therapeutics Corporation carries total debt of $0 against cash of $1.56B, resulting in a net cash position of +$1.56B. For the full balance sheet, see the Financials → Balance Sheet tab.
Frequently asked questions
UTHR cash on hand · 5 questionsAs of December 31, 2025, United Therapeutics Corporation (UTHR) has $1.56B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $1.56B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $2.15B. Data sourced from the annual 10-K filing via FMP.
▸ Source: FMP /balance-sheet-statement · US GAAP · United Therapeutics Corporation · United Therapeutics Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025